Table 3.
AZD9412 (N = 61) | Placebo (N = 60) | Ratio of proportions (95% CI) AZD9412 vs Placebo | p‐value | |
---|---|---|---|---|
n (%) | n (%) | |||
Treatment Days 1 to 15 |
17 (27.9%) | 18 (30.0) | 0.85 (0.48, 1.52) | .59 |
Post‐treatment Days 15 to 30 |
9 (14.8) | 12 (20.0) | 0.74 (0.34, 1.61) | .45 |
CompEx: composite endpoint for severe exacerbations; n: number; and vs: versus.